首页> 外国专利> THIO-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC PHOSPHONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM

THIO-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC PHOSPHONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM

机译:硫取代的含氮磷酸酯化合物用于异常钙和磷酸盐的代谢处理

摘要

The present invention relates to thio-substituted, nitrogen-containing heterocyclic phosphonate compounds, including bisphosphonates, phosphonoalkylphosphinates, phosphonocarboxylates, and phosphonosulfonates, and the pharmaceutically-acceptable salts and esters thereof useful for the treatment and prevention of osteoporosis and arthritis. These compounds have the general structure: IMAGE (a) Z is a monocyclic or polycyclic heterocyclic ring moiety containing one or more heteroatoms selected from O, S, or N, at least one of which is N; (b) Q is covalent bond; O, S, N, or NR1; (c) R is COOH, SO3H, PO3H2, or P(O)(OH)R4, wherein R4 is substituted or unsubstituted C1-C8 alkyl; (d) each R1 is independently selected from -SR6; -R8SR6; nil; hydrogen; unsubstituted or substituted C1-C8 alkyl; unsubstituted or substituted aryl; hydroxy; -CO2R3; -O2CR3; -NR32; -OR3; -C(O)N(R3)2; -N(R3)C(O)R3; substituted or unsubstituted benzyl; nitro; or combinations thereof; (e) R2 is one or more substituents on atoms in the Z moiety and is independently selected from -SR6 and -R8SR6; where R6 is H; -CO2R3; -O2CR3; -NR32; -N(R)3C(O)R3; and nil; hydrogen; unsubstituted or substituted C1-C8 alkyl; unsubstituted or substituted aryl; hydroxy; substituted or unsubstituted benzyl; nitro; or combinations thereof; (f) each R3 is independently selected from hydrogen; substituted or unsubstituted C1-C8 alkyl; or R8SR6; (g) R5 is selected from -SR6; R8SR6, hydrogen; hydroxy; amino; halogen; unsubstituted or substituted C1-C8 alkyl; and (h) R6 is independently selected from H; -C(O)R7; C(S)R7; C(O)NR72; C(S)NR72; C(O)(OR7); and C(S)(OR7); wherein R7 is hydrogen; or unsubstituted or substituted C1-C8 alkyl; (i) R8 is a substituted or unsubstituted C1-C8 alkyl; and at least one of R1, R2, R3 or R5 must be SR6 or R8SR6.
机译:本发明涉及硫取代的含氮杂环膦酸酯化合物,包括双膦酸酯,膦酰基烷基膦酸酯,膦酸酯羧酸酯和膦酸酯磺酸酯,及其药学上可接受的盐和酯,其用于治疗和预防骨质疏松症和关节炎。这些化合物具有一般结构:<图像>(a)Z为含有一个或多个选自O,S或N的杂原子的单环或多环杂环部分,其中至少一个为N; (b)Q为共价键; O,S,N或NR1; (c)R为COOH,SO3H,PO3H2或P(O)(OH)R4,其中R4为取代或未取代的C1-C8烷基; (d)每个R1独立地选自-SR6; -R8SR6;零;氢;未取代或取代的C1-C8烷基;未取代或取代的芳基;羟基-CO 2 R 3; -O2CR3; -NR32; -OR3; -C(O)N(R3)2; -N(R3)C(O)R3;取代或未取代的苄基;硝基或其组合; (e)R2是Z部分中原子上的一个或多个取代基,并且独立地选自-SR6和-R8SR6;其中R6为H; -CO 2 R 3; -O2CR3; -NR32; -N(R)3C(O)R3;和零;氢;未取代或取代的C1-C8烷基;未取代或取代的芳基;羟基取代或未取代的苄基;硝基或其组合; (f)每个R 3独立地选自氢;取代或未取代的C1-C8烷基;或R8SR6; (g)R5选自-SR6; R8SR6,氢;羟基氨基卤素;未取代或取代的C1-C8烷基; (h)R6独立地选自H; -C(O)R 7; C(S)R7; C(O)NR72; C(S)NR 72; C(O)(OR7);和C(S)(OR7);其中R7是氢;或未取代或取代的C1-C8烷基; (i)R8是取代或未取代的C1-C8烷基; R1,R2,R3或R5中的至少一个必须为SR6或R8SR6。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号